StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Teva Pharma (TEVA) oncology assets said to draw Fresenius Mylan, Novartis interest - Bloomberg
August 4, 2017 10:57 AM
Teva Pharma (NYSE ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Mergers and Acquisitions
Rumors
Next Articles
Teva Pharma (TEVA) Granted FDA Approval of QVAR® RediHaler (Beclomethasone Dipropionate HFA) Inhalation Aerosol
August 7, 2017 8:01 AM